Showing results (1141-1150 of 9,901) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 1, 1995
Outpatient bone marrow harvesting: an updateM J Kovacs, M Crump, A Keating
Bone Marrow Transplantation|January 1, 1995
Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study GroupJ C Biggs, K A Atkinson, V Booker, et al.
Bone Marrow Transplantation|January 1, 1995
Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantationK L Liu, R Herbrecht, B Lioure, et al.
Bone Marrow Transplantation|January 1, 1995
Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxisM Vassilomanolakis, G Plataniotis, G Koumakis, et al.
Bone Marrow Transplantation|January 1, 1995
Inhibition of CFU-C growth by VP-16 containing plasma samples obtained from patients after conditioning therapy for bone marrow transplantationW H Krüger, C Berger, K B Mross, et al.
Bone Marrow Transplantation|January 1, 1995
TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHDM Remberger, O Ringden, L Markling
Bone Marrow Transplantation|October 1, 1994
Thrombotic microangiopathy following bone marrow transplantationA R Pettitt, R E Clark
Bone Marrow Transplantation|October 1, 1994
Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host diseaseD T Harris, J LoCascio, F J Besencon
Bone Marrow Transplantation|October 1, 1994
Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantationP J Browett, J Nelson, S Tiwari, et al.
Bone Marrow Transplantation|February 1, 1995
Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicityT Murase, M S Anscher, W P Petros, et al.
Pageof 991